Description: In recent weeks, The Cigna Group Foundation awarded ten St. Louis nonprofits funding as part of its multi-year Health Equity Impact Fund to address barriers to mental health care and substance use disorder treatment. This initiative underscores Cigna's growing commitment to health equity and mental wellness in partnership with local organizations targeting underserved communities. We’ll examine how the anticipated margin pressure from Cigna’s pharmacy benefit transition could influence the...

Description: CVS posts a sharper MBR as PDR impacts ease and government business strengthens while maintaining a cautious full-year outlook.

Description: Even though Cigna has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Description: The Cigna Group (NYSE:CI) is one of the best low volatility large cap stocks to invest in. Bank of America Securities analyst Kevin Fischbeck maintained a Buy rating on The Cigna Group (NYSE:CI) on November 21, setting a price target of $378. The analyst based the rating on the company’s overall financial outlook and strategic […]

Description: The U.S. dental insurance market is poised for significant growth, projected to surge from $60.2 billion in 2024 to $111.89 billion by 2033, driven by a CAGR of 7.13%. This expansion is fueled by increasing oral health awareness, the rising cost of dental care, and a focus on preventive care. Key growth catalysts include employer-sponsored insurance plans and advances in dental technology. However, challenges like affordability and limited coverage scope persist. The market is segmented into var

Description: Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.

Description: NEW YORK, November 25, 2025--Empire State Radiology, P.C. (ESR), a Radiology Partners-affiliated practice, announced a new, multi-year agreement with Cigna Health bringing ESR into Cigna’s network of expanding participating providers beginning November 15, 2025.

Description: Cigna Group (CI) investors have seen shares edge higher this week, with a 3% return over the past day and a 2% gain over the past week. Although the performance over the past month has been more subdued, Cigna’s recent momentum has drawn attention from those tracking healthcare stocks. See our latest analysis for Cigna Group. Cigna Group has started to regain some traction, with recent share price gains helping to offset a challenging longer-term story. Despite this uptick, Cigna’s one-year...

Description: The Cigna Group (NYSE:CI) is among the stocks Wall Street analysts are watching closely. On November 12, Lance Wilkes, an analyst at Bernstein, trimmed the price target on The Cigna Group (NYSE:CI) to $294 from $346, while maintaining a ‘Market Perform’ rating on the stock. The firm believes the company’s new pharmacy benefit manager (PBM) […]

Description: A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to

Description: The startup’s rapid growth suggests that enerprises are embracing AI agents.

Description: Cullen Capital Management, LLC, operating under the name Schafer Cullen Capital Management, Inc. (SCCM), has released its “SCCM Value Equity Strategy” third-quarter investor letter. A copy of the letter can be downloaded here. The US equity market continued the rally in the third quarter, with the S&P 500 returning 8.1% and the Russell 1000 Value surging 5.3%. […]

Description: Wondering if Cigna Group stock is actually a bargain right now? You are not alone, as many investors are reevaluating its place in their portfolios. While the stock has rallied 5.1% in the past week, it is still down 14.2% over the last year and 1.2% year to date, suggesting shifting market sentiment and maybe some opportunities. Recently, headlines have focused on sector-wide shifts in healthcare policy and changing insurance demand, both of which have sharply influenced investor attitudes...

Description: By David Bautz, PhD NASDAQ:ABEO READ THE FULL ABEO RESEARCH REPORT Business Update First Patient Treated with Zevaskyn® Pushed to 4Q25 The first patient treated with Zevaskyn was pushed back to the fourth quarter of 2025 following the optimization of a release assay during the third quarter of 2025. A full batch of drug product was produced following biopsy collection from a patient in August

Description: Initiates Full Year 2025 Revenue Guidance of $173.0 Million to $173.5 MillionMOUNTAIN VIEW, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in artificial intelligence (AI) technology for coronary artery disease (CAD), today reported financial results for the three months ended September 30, 2025. Third Quarter 2025 Highlights Total revenue of $46.3 million, a 41% increase year-over-yearGross margin of 76.5%, non-GAAP gross margin of 76.8%Net opera

Description: SEM's Q3 earnings drop 11.5% year over year due to the rising cost of services, despite a revenue beat and raised 2025 EPS guidance.

Description: The Cigna Group recently reported strong third quarter results, introduced Dr. Amy Flaster as Chief Medical Officer in an expanded enterprise role, and announced a new collaboration with Headspace to broaden everyday mental health support for members starting January 2026. This series of developments underscores Cigna's ongoing push to combine clinical leadership, digital innovation, and enhanced member-focused services within its healthcare and pharmacy businesses. We'll examine how the...

Description: Global health company The Cigna Group (NYSE: CI) announced that Ann Dennison, EVP and CFO of The Cigna Group, and Adam Kautzner, President of Express Scripts and Evernorth Care Management, will present at the UBS Global Healthcare Conference today, November 12, 2025, in Palm Beach Gardens, FL.

Description: Major payers with a presence in the ACA, Medicare or Medicaid posted an average operating margin of -1.4% in the third quarter. The market “continues to be challenging,” complicating margin recovery plans, one expert said.

Description: A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns. This divergence was stark: the tech-heavy Nasdaq struggled, losing 0.2%, while the Dow rallied. This shift away from tech was triggered by a series of negative catalysts in the AI sector. AI cloud provider CoreWeave slid on disappointing guidance, while chip darling Nvidia

Description: Although Cigna Group has lagged the broader market, analysts remain bullish about its prospects.

Description: ADDISON, Texas, November 10, 2025--Concentra®, (NYSE: CON) the nation’s largest provider of occupational health services, today announced the appointment of Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer. In this role, he will ensure Concentra’s data strategy and governance, technology enablement, and insight generation are aligned with enterprise growth priorities.

Description: Wall Street was buoyed by investor optimism that the longest federal government shutdown in U.S. history could be nearing an end.

Description: President Donald Trump wrote that "hundreds of billions" in federal funding should be shifted from "money sucking" health insurers to the public.

Description: Among rising rates of anxiety in the workforce, Cigna Healthcare, the health benefits division of The Cigna Group (NYSE: CI), is expanding mental health support to address the everyday moments of stress, burnout, and sleep issues through an industry-first collaboration with Headspace. Millions of Cigna Healthcare customers will benefit from exclusive digital features, such as custom content and seamless navigation to in-network clinicians for higher levels of care, in addition to Headspace's dig

Description: Cigna Group (CI) has flagged upcoming margin pressure in its pharmacy benefit management business through 2026 and 2027, as it adopts a rebate-free pricing approach and renews contracts under tighter terms. Investors are already weighing how these changes could affect growth and valuations going forward. See our latest analysis for Cigna Group. Cigna Group’s share price rebounded 8.3% over the past week, recovering part of a sharp 12% drop in the last month that followed updates on tighter...

Description: President Donald Trump wrote that "hundreds of billions" in federal funding should be shifted from "money sucking" health insurers to the public.

Description: CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer recently shared thoughts on. Cramer discussed the company’s “reinvention,” as he said: “Sadly, this tale of reinvention doesn’t happen very often, but when it does, I celebrate it. For example, I really like what David Joyner’s doing with the turnaround at CVS. Value creation, […]

Description: Global health company The Cigna Group (NYSE: CI) today announced that Dr. Amy Flaster has been named Chief Medical Officer of The Cigna Group, effective November 1. Dr. Flaster, who joined the company last year as Chief Medical Officer of Cigna Healthcare, will now serve in an expanded enterprise role across both Cigna Healthcare and Evernorth. In this capacity, she will spearhead efforts to advance clinical excellence, introduce innovative care models, strengthen and grow clinical teams, and le

Description: The insurer reports better-than-expected quarterly earnings and reaffirms its full-year adjusted earnings guidance.

Description: Goldman Sachs analyst Scott Fidel lowered the firm’s price target on Cigna (CI) to $330 from $370 and keeps a Buy rating on the shares. Cigna shares fell 18% after management disclosed major structural changes to the Evernorth PBM business, signaling margin compression beginning in 2026, the analyst tells investors in a research note. The decline reflects investor surprise over earlier-than-expected margin resets tied to a new rebate-free pricing model and lower-margin renewals with key clients

Description: The numbers will come at the tail end of what has been a bumpy earnings season for the large managed-care companies.

Description: Pre-Market Futures: The S&P 500 and NASDAQ futures are trading down over 1% on Tuesday, following Palantir’s 6.9% decline despite beating earnings expectations and giving strong forward guidance. Concerns over an AI bubble continue to mount. Tuesday’s sell-off follows a wild start to the week, during which the Dow Jones Industrial Average traded lower due ... Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More

Description: The Cigna Group ( NYSE:CI ) investors will be delighted, with the company turning in some strong numbers with its...

Description: Cigna Group (CI) saw its net profit margin rise to 2.3% from 1.3% a year ago, while earnings growth accelerated 102.3% year over year, marking a sharp reversal from its five-year average decline of 11.9%. The company’s forecasted earnings growth of 6.41% per year trails the broader market, but investors may take comfort in the stock’s 10.6x price-to-earnings ratio, its position below fair value estimates, and its appealing dividend profile. With only one minor risk flagged and a handful of...

Description: “The market is entirely too complacent about downside risks,” says one observer. The troubles go beyond a few rough earnings reports.

Description: While the market is priced for perfection, some companies are reporting results that are less than perfect.

Description: Download the Complete Report Here By Brandon Hornback America’s broken healthcare system should welcome a new technology that aims to please patients and investors alike. Berto Acquisition Corp. (NASDAQ: TACO), headed by SPAC veteran Harry You, has signed a non-binding letter of intent to acquire OnMed in a deal likely valued between $500 million to […]

Description: While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.

Description: The Cigna Group (CI) reports robust third-quarter results with $69.7 billion in revenue, while navigating challenges from new strategic initiatives.

Description: Shares of health insurance company Cigna (NYSE:CI) fell 14.3% in the morning session after the company reported underwhelming third-quarter results. Revenue grew 9.5% year-on-year to $69.75 billion, beating estimates by 3.6%.

Description: Yahoo Finance host Josh Lipton recaps some of the top stories on Wall Street on Yahoo Finance's Market Minute, including Cigna (CI) warning investors about margin pressures, gold (GC=F) demand surging, and Hershey's (HSY) weak Halloween candy sales. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.

Description: CI's Q3 earnings and revenues beat estimates as Evernorth Health Services powers growth despite healthcare headwinds.

Description: The company said that profit margins for its pharmacy-benefit-services division would slide over the next two years.

Description: Cigna Group logged higher profit and revenue in the third quarter, boosted by continued strength in its pharmacy-benefit business Evernorth.

Description: The Cigna Group (NYSE:CI) is one of the most undervalued large cap stocks to buy right now. On October 28, Andrew Mok CFA from Barclays maintained a Buy rating on Cigna, with a price target of $383.00. Earlier on October 14, Goldman Sachs analyst Scott Fidel initiated coverage of Cigna with a Buy rating and […]

Description: Although the revenue and EPS for Cigna (CI) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Description: Overall, Cigna expects earnings to grow next year after posting a solid third quarter. But investments in a new PBM model and discounted contracts for some big clients could lower Express Scripts’ profitability, executives said.

Description: Cigna (CI) delivered earnings and revenue surprises of +1.69% and +3.59%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: Investing.com -- The Cigna Group (NYSE:CI) on Thursday reported third-quarter earnings that exceeded analyst expectations, but shares in the global health company fell sharply after CEO David Cordani warned of profit headwinds in the company’s pharmacy benefits business over the next two years.

Description: Health insurance company Cigna (NYSE:CI) announced better-than-expected revenue in Q3 CY2025, with sales up 9.5% year on year to $69.75 billion. Its non-GAAP profit of $7.83 per share was 2.5% above analysts’ consensus estimates.

Description: BLOOMFIELD, Conn. AP) — The Cigna Group (CI) on Thursday reported third-quarter net income of $1.87 billion. The Bloomfield, Connecticut-based company said it had net income of $6.98 per share.

Description: Global health company The Cigna Group (NYSE: CI) today reported third quarter 2025 results that reflect strategic execution across its diverse portfolio of businesses.

Description: The Cigna Group (NYSE:CI) is included among the 13 Most Undervalued Dividend Stocks to Buy According to Wall Street Analysts. The Cigna Group (NYSE:CI) is an American mul‍t‍inationa‌l company offer⁠ing managed healthcare a‍nd insurance services. On October 27,⁠ JPMorgan mainta‌ined an Overwe‌ight rating on The Cigna Group (NYSE:CI) followin⁠g an announcemen⁠t from‍ its Evernorth unit […]

Description: UnitedHealth Group's (UNH) stock hasn't received the post-earnings rally that investors may have hoped for, but the medical giant was able to provide subtle signs that its operations are stabilizing.

Description: Cigna has outperformed peers as the managed-care industry faces policy challenges. Affordable Care Act subsidies are set to expire and premiums for next year are up 26%.

Description: CI's Q3 results hinge on strong Evernorth growth and surging investment income, but lower premiums and rising costs may weigh on margins.

Description: CNC's Q3 earnings beat estimates as strong premium growth and rising membership in PDP and Marketplace units offset higher medical costs.

Description: Health insurance company Cigna (NYSE:CI) will be reporting results this Thursday before the bell. Here’s what to expect.

Description: UNH's Q3 earnings beat estimates on solid commercial membership gains and Optum Rx strength, though profits fall sharply on rising medical costs.

Description: Evernorth, the health services arm of The Cigna Group, recently announced the rollout of a rebate-free pharmacy benefit model that eliminates traditional drug rebates and introduces cost-plus reimbursement for pharmacies across its client base. This move marks a substantial change for the pharmacy benefit manager landscape, with the aim of increasing transparency, lowering prescription costs for consumers, and altering industry pricing dynamics. We'll explore how Cigna's shift to a...

Description: Besides Wall Street's top-and-bottom-line estimates for Cigna (CI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.

Description: Cigna Group is launching a new rebate-free pharmacy benefit model which aims to bring down drug costs directly at the counter.

Description: The massive PBM’s announcement comes as the drug middlemen attempt to lessen regulatory scrutiny. The company also said it will move to a cost-plus reimbursement model for in-network pharmacies.

Description: Evernorth, the health services division of The Cigna Group (NYSE:CI) today announced a new rebate-free pharmacy benefit model designed to help Americans stay healthy and get the medications they need by lowering costs, improving transparency, and supporting local pharmacies so care is always within reach.

Description: Cigna Group (CI) shares have shown a little movement recently. With no major headline driving the action, investors are keeping an eye on how the stock’s valuation lines up with its steady financial performance over the past year. See our latest analysis for Cigna Group. After a strong performance earlier in the year, Cigna Group’s share price has mostly held steady near $301.78, reflecting investor confidence in its financial profile even as the 1-year total shareholder return sits slightly...

Description: U.S. News & World Report, the global authority in health care rankings and consumer advice, today announced the 2026 Best Insurance Companies for Medicare Advantage and Best Insurance Companies for Medicare Part D.

Description: Molina (MOH) delivered earnings and revenue surprises of -53.65% and +5.28%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.51 per share of its common stock, payable on December 18, 2025 to shareholders of record as of the close of business on December 4, 2025.

Description: The Cigna Group (NYSE:CI) is one of the 11 Dirt Cheap Stocks to Buy According to Analysts. On October 15, Wolfe Research lowered its price target on The Cigna Group (NYSE:CI) from $345 to $325 and kept an Outperform rating. Wolfe Research pointed out that even after moderating its numbers slightly, it still sees The […]

Description: HealthEquity rolls out GLP-1 telehealth and direct HSA enrollment platforms, targeting affordability and growth amid rising healthcare costs and regulatory expansion.

Description: Thinking about what to do with Cigna Group stock right now? You are not alone. Investors have been watching the company’s price movements closely, especially after a rollercoaster year that saw shares climb an impressive 76.3% over five years but fall 9.2% in the past twelve months. This kind of long-term bounce paired with recent softening leaves many asking if there is still value in the stock, or if risks have started to outweigh rewards. Dig a little deeper and the story gets even more...

Description: Nearly all 55 million Medicare users overpay for prescriptions. Expert Katy Votava explains how to compare Part D plans and save thousands.

Description: Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.